I just had a re-read of the latest PD1-Vaxx announcement. Below is an excerpt:
After 6 weeks (day 43) treatment with PD1-Vaxx, one patient’s tumor was non-measurable indicating a complete response (CR), with three patients showing stabilization of disease (SD) and a single patient progressing (PD). The status of two patients from cohort 1 (1 x SD, 1 x CR) were unchanged 2 IMUGENE LIMITED ACN 009 179 551 at day 85. These are encouraging results in patients who have progressed after previous treatment with checkpoint inhibitors including Keytruda®, Opdivo® or Tecentriq®. Further results and scans are scheduled over the coming weeks.
I actually missed the bold italic bit as I was busy when the announcement was released so had skim read it. I did not realise the patients had no success with the likes of Keytruda, Opdivo and Tecentriq! If the results is confirmed over the scheduled scans and replicated in Phase II, I dare say the likes of BeiGene might actually come knocking! That is if they truly want to knock Keytruda and Opdivo off their perch.
- Forums
- ASX - By Stock
- IMU
- Media Thread
Media Thread, page-851
-
- There are more pages in this discussion • 13,484 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $417.2M |
Open | High | Low | Value | Volume |
5.7¢ | 5.8¢ | 5.6¢ | $1.040M | 18.27M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 1917207 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 653942 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 1917207 | 0.056 |
14 | 3386705 | 0.055 |
25 | 3644629 | 0.054 |
15 | 2901167 | 0.053 |
19 | 1811203 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 653942 | 7 |
0.059 | 3329802 | 11 |
0.060 | 1565197 | 16 |
0.061 | 2979688 | 13 |
0.062 | 332268 | 4 |
Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |